Associated Papers
Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias.
Dron JS et al.
Bmc Medical Genomics, 2020
32041611 (PubMed )
Supplement: 12920_2020_669_MOESM1_ESM.xlsx › Supp_Table_4
The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma.
Matsushita H et al.
Oncoimmunology, 0
28920005 (PubMed )
Supplement: supplement_1.zip › KONI_A_1338996_s04.xlsx › Supplementary_Table_S3
Select a paper to view details